tetrandrine has been researched along with Bagassosis in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Deng, X; Li, S; Luo, Y; Tan, F; Tan, X; Tang, M; Xiao, X | 1 |
Cai, B; Gong, X; Liu, C; Xiao, X; Yuan, X | 1 |
Wang, C; Zheng, X | 1 |
Li, T; Wang, HQ | 1 |
Peng, LJ; Zhu, QS | 1 |
1 review(s) available for tetrandrine and Bagassosis
Article | Year |
---|---|
[Research on the therapeutic effects of drugs on patients with pneumoconiosis in China].
Topics: Acetylcysteine; Benzylisoquinolines; Bronchoalveolar Lavage; China; Forced Expiratory Volume; Humans; Pneumoconiosis; Pulmonary Fibrosis; Quinolines; Research; Respiratory Tract Infections; Treatment Outcome; X-Ray Film | 2016 |
2 trial(s) available for tetrandrine and Bagassosis
Article | Year |
---|---|
[Effects of tetrandrine combined with large volume whole lung lavage on the quality of life and oxidative stress of pneumoconiosis patients].
Topics: Aged; Benzylisoquinolines; Bronchoalveolar Lavage; Female; Humans; Male; Middle Aged; Oxidative Stress; Phytotherapy; Pneumoconiosis; Quality of Life; Treatment Outcome | 2014 |
[Study on the healing effect of pneumoconiosis with tetrandrine and massive whole-lung lavage].
Topics: Adult; Benzylisoquinolines; Bronchoalveolar Lavage; Collagen Type III; Combined Modality Therapy; Humans; Male; Middle Aged; Pneumoconiosis; Transforming Growth Factor beta1; Treatment Outcome | 2012 |
2 other study(ies) available for tetrandrine and Bagassosis
Article | Year |
---|---|
Tetrandrine slows the radiographic progression of progressive massive fibrosis in pneumoconiosis: a retrospective cohort study.
Topics: Humans; Lung; Pneumoconiosis; Pulmonary Fibrosis; Retrospective Studies | 2023 |
[Combination treatment of tetrandrine and huanggen tablet in the 60 cases of pneumoconiosis].
Topics: Benzylisoquinolines; Calcium Channel Blockers; Combined Modality Therapy; Humans; Pneumoconiosis; Tablets | 2014 |